SUBSCRIBE
SUBSCRIBE
News   Business   Deals

BioTrove, Inc. Cancels $75 Million IPO

December 18, 2008 | 
1 min read
BioTrove Inc., a Woburn, Mass.-based maker of instruments and consumables for genomic analysis, high-throughput screening and molecular diagnostics, has withdrawn registration for a $75 million IPO, citing unfavorable market conditions. I
IPO
MORE ON THIS TOPIC
USD dollar banknote with USA flag and stock market graph chart for currency exchange and global trade forex concept.
Business
US biotechs take lion’s share of $54.5B VC money raised since 2025
October 26, 2026
 · 
1 min read
 · 
Gabrielle Masson
3d Japanese candlestick chart and line chart in blue metal style, isolated on dark blue background. Stock or crypto chart icon in 3d vector illustration. Vector illustration
IPO
Biotech IPOs raise $7.5B as sector’s performance rally flattens
October 26, 2026
 · 
1 min read
 · 
Gabrielle Masson
Perspective view of supermarket aisle. Supermarket with colorful shelves of merchandise and front door and supermarket food cart. Cartoon vector illustration
Immunology and inflammation
Gilead shops in IL-23, inking $1.3B upfront I&I deal with China’s PepStar
October 23, 2026
 · 
1 min read
 · 
Annalee Armstrong
3d sketch poster trend collage image of hands hold chess figurine knight queen rival china america trade war economic problem.
China
US explores China biotech restrictions, exempts licensing deals
October 23, 2026
 · 
3 min read